Cell-Targeted Therapy Shows Early Promise Against MS
Treatment targeting specific white blood cells in the immune system known as B cells may help people with multiple sclerosis (MS), new research suggests.
The study involved 231 people with a form of MS that’s called relapsing-remitting. For these patients, there are times when their disease is very active. At other times, the condition becomes less intense and they may experience a full or partial recovery of function.
Press + Media
- Print Press Coverage
- TV Press Coverage
- Online Press Coverage
- Foundation Videos
- Foundation Blog
- Press Materials
Topics of Interest
Posted: Aug 12, 2016By: Kristina Marie Dizard When it heals the soul but hurts the body: Finding a healthy balance. ...
Posted: Jan 31, 2017The Race to Erase MS annual event is a celebrity ...
Posted: Apr 01, 2016Held at The Beverly Hilton, The Race to Erase MS ...
Posted: May 12, 2014Please join us for an opportunity to hear from our ...